RNA Therapeutics Market Size

RNA Therapeutics Market Size

RNA Therapeutics Market size was valued at USD 19.2 billion in 2023 and is estimated to grow at a CAGR of 5.7% from 2024 to 2032. The rising incidence of infectious diseases has propelled the demand for innovative and targeted treatment options, with RNA therapeutics emerging as a promising solution.

To get key market trends

  Download Free Sample

Similarly, increasing incidence of rare diseases and genetic disorders has fuelled the demand for personalized medicine, where RNA therapies play a pivotal role. For instance, as per WHO, genetic disorders and congenital abnormalities occur in about 2%-5% of all live births and account for up to 30% of paediatric hospital admissions in industrialized countries. This high incidence of genetic disorders contributes to an increased demand for new therapeutic interventions, thereby fostering the market expansion.

Additionally, the success of RNA-based COVID-19 vaccines has highlighted the potential of RNA therapeutics, garnering significant attention and investment. Thus, as the field continues to mature, the RNA therapeutics market is poised for continued growth.

RNA therapeutics refers to a class of medical interventions that utilize ribonucleic acid (RNA) molecules to treat or prevent diseases. RNA, a molecule involved in the expression of genetic information, plays a crucial role in the synthesis of proteins in cells. RNA therapeutics hold promise for treating a wide range of diseases, including genetic disorders, cancer, infectious diseases, and various other conditions.